Hoth Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Hoth Therapeutics generated cash of -$8,447,094, which is more than the previous year. Cash used in financing activities reached the amount of $11,317,353 last year. Net change in cash is therefore $2,863,741.
Cash Flow
| 2017 | -465.24K | -303.68K | 1.99M |
|---|---|---|---|
| 2018 | -2.10M | 0 | 1.15M |
| 2019 | -4.94M | -895K | 7.45M |
| 2020 | -6.13M | -1.83M | 8.72M |
| 2021 | -12.09M | -165.35K | 18.19M |
| 2022 | -9.29M | 1.16M | 6.03M |
| 2023 | -8.44M | 0 | 11.31M |
HOTH Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.42M | 8.53M | 2.62M | 1.89M | 282.62K | 1.23M | 0 |
Operating activities | |||||||
Net income | -7.84M | -11.37M | -14.31M | -7.19M | -7.70M | -2.49M | -2.01M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 0 | 0 | 0 | 1.04K | 1.22K | 1.22K | 188 |
Stock-based compensation expense | 216.42K | 620.79K | 1.32M | 737.74K | 2.49M | 0 | 1.47M |
| Deferred income tax benefit | 216.42K | 620.79K | 1.32M | 737.74K | 2.49M | 0 | 1.47M |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -700.75K | 590.63K | 535.34K | -151.98K | 267.35K | 94.35K | 47.92K |
Cash generated by operating activities | -8.44M | -9.29M | -12.09M | -6.13M | -4.94M | -2.10M | -465.24K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | -2.55M | -2.30M | -800K | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -74K | -116.97K | -167.45K | -95K | 0 | -303.68K |
Acquisitions Net | 0 | 0 | 116.97K | -410K | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 1.16M | -165.35K | -1.83M | -895K | 0 | -303.68K |
Financing activities | |||||||
Common Stock Issued | 11.31M | 5.98M | 17.83M | 8.66M | 7.45M | 1.18M | 1.99M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 132.16K | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 11.31M | 6.03M | 18.19M | 8.72M | 7.45M | 1.15M | 1.99M |
Net Change In Cash | 2.86M | -2.10M | 5.90M | 738.80K | 1.60M | -947.81K | 1.23M |
Cash at end of period | 9.29M | 6.42M | 8.53M | 2.62M | 1.89M | 282.62K | 1.23M |
| Data source | Data source | Data source | Data source | Data source | Data source |